Dr. Aditya Juloori, MD
Claim this profileUniversity of Chicago
Area of expertise
Lung Cancer
Aditya Juloori, MD has run 1 trial for Lung Cancer. Some of their research focus areas include:
Squamous Cell Carcinoma
Aditya Juloori, MD has run 1 trial for Squamous Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago
Clinical Trials Aditya Juloori, MD is currently running
[225Ac]-FPI-2068
for Cancer
This is a first-in-human, Phase 1, non-randomized, multicenter, open-label clinical study designed to investigate the safety, tolerability, dosimetry, biodistribution, and pharmacokinetics (PK) of \[225Ac\]-FPI-2068, \[111In\]-FPI-2107, and FPI-2053 in metastatic and/or recurrent solid tumors (HNSCC, NSCLC, mCRC, PDAC, GC, RCC).
Recruiting
1 award
Phase 1
6 criteria
GD2-SADA:177Lu-DOTA Complex
for Small Cell Lung Cancer
This trial tests a new treatment for certain cancers using a two-part method. The first part finds and attaches to cancer cells, and the second part delivers radiation to kill them. It aims to see if this treatment is safe and can be tolerated by patients with Small Cell Lung Cancer, Sarcoma, and Malignant Melanoma.
Recruiting
1 award
Phase 1
9 criteria
More about Aditya Juloori, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Aditya Juloori, MD has experience with
- [111In]-FPI-2107
- [225Ac]-FPI-2068
- FPI-2053
- GD2-SADA:177Lu-DOTA Complex
Breakdown of trials Aditya Juloori, MD has run
Lung Cancer
Squamous Cell Carcinoma
Kidney Cancer
Stomach Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aditya Juloori, MD specialize in?
Aditya Juloori, MD focuses on Lung Cancer and Squamous Cell Carcinoma. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Aditya Juloori, MD currently recruiting for clinical trials?
Yes, Aditya Juloori, MD is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Aditya Juloori, MD has studied deeply?
Yes, Aditya Juloori, MD has studied treatments such as [111In]-FPI-2107, [225Ac]-FPI-2068, FPI-2053.
What is the best way to schedule an appointment with Aditya Juloori, MD?
Apply for one of the trials that Aditya Juloori, MD is conducting.
What is the office address of Aditya Juloori, MD?
The office of Aditya Juloori, MD is located at: University of Chicago, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.